Last edition
News about "EU vaccine approval"
EC Approves Bavarian Nordic's Mpox Vaccine for Children
European Commission (EC) approves Bavarian Nordic's MVA-BN mpox/smallpox vaccine for children aged 2-11 years, expanding protection against mpox, smallpox and vaccinia.
EU Vaccine Approval | 07/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members